Explorer
Bharat Biotech seeks emergency use approval for Covaxin
After Pfizer and Serum Institute of India (SII), Bharat Biotech has applied for the emergency use approval for its Coronavirus vaccine, Covaxin. The Hyderabad based company has written to written to central drug regulator seeking emergency use authorization.
The vaccine has been developed by Bharat Biotech in collaboration with Indian Council of Medical Research (ICMR)
The vaccine has been developed by Bharat Biotech in collaboration with Indian Council of Medical Research (ICMR)
India
Politics: Yogi Adityanath's Remarks on Riots Trigger Political War Ahead of UP Elections
Madhya Pradesh: Police End Cheeta Protest in Madhya Pradesh's Chhatarpur
Monsoon Crisis: Heavy Monsoon Rains Trigger Floods and Landslides Across Northern Himalayan States
Weather & Public Safety: Heavy Rains Raise Flood Fears in Himachal, Viral Videos Highlight Dangerous Public Negligence
Parliament: Delimitation Emerges as Key Flashpoint Ahead of Parliament's Monsoon Session
View More
Top Headlines
News
CJP Issues Guidelines Ahead Of 'Chalo Parliament' March, Makes Appeal To Protesters
India
Rebel TMC MPs Elect Floor Leader, Chief Whip At Parliamentary Party Meeting
News
Exclusive | Ex-IB Chief Tapan Deka Likely To Be Jammu and Kashmir LG
Business
OPINION | India-UK CETA: Why Winning Market Matters More Than Signing The Deal
Trending News
